Schubert Jonckheer & Kolbe
Representing Shareholders, Employees, and Consumers for Over 30 Years
MiMedx_logo_CMYK.png

News

News & Investigations

News and Investigations

Join a Class Action

We're actively investigating new cases on behalf of consumers, employees, and shareholders. If you've purchased any of these consumer products or own stock in any of these companies, please contact us to discuss your legal rights.

 

Humana Inc. (NYSE: HUM) Investor Alert: Securities Fraud Case Moves Forward Following 22% Stock Drop; Schubert Jonckheer Investigating

Schubert Jonckheer & Kolbe LLP is investigating potential wrongdoing at Humana Inc. (NYSE: HUM) following a court ruling that key claims in a securities fraud lawsuit against Humana and its former CEO and CFO will move forward.

The lawsuit alleges Humana misled investors between July 2022 and October 2024 regarding its exposure to rising costs as patients returned for medical care after the pandemic, causing its stock to trade at artificially inflated prices. U.S.

District Judge Jennifer L. Hall found the complaint sufficiently alleged that defendants acted with an intent to defraud in making false and misleading statements. During this period, insiders sold over $104 million in stock. When the truth was fully revealed in October 2024 and Humana reported sharp declines in many of its plans’ Star ratings, the stock price fell 22%.

We are investigating potential wrongdoing by Humana’s directors and officers in connection with these allegations.

If you own Humana stock, you may have legal options. To obtain additional information about your legal rights, please fill out the form below.

InvestigationsMatt FotiInvestigations, Data Breach